Medicine recalls
|
| |
| The United Kingdom: Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets (batch number: V2500425) to the patient, pharmacy and wholesaler level as a precautionary measure due to an error at the manufacturing site. Amarox Limited has received one complaint to date from an adult patient who reported the adverse event of headache, where it was identified that a pack of Sertraline 100 mg film-coated tablets (batch number: V2500425) contains one blister strip of Citalopram 40 mg film-coated tablets inside the sealed carton. Both products were manufactured at the same manufacturing site and the error appears to have occurred during secondary packaging of the blister strips into the cartons.
Sertraline and citalopram are both selective serotonin reuptake inhibitors used to treat depression, anxiety disorders, and related mental health conditions by boosting brain serotonin.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-amarox-limited-sertraline-100mg-film-coated-tablets-el-26-a-slash-22
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Apr 29, 2026
Issued at HKT 15:15
|
| |
